Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study.
Because the results with cobalt-57-bleomycin (57Co-bleo) as a tumour-seeking agent in patients with pulmonary tumours were promising, a prospective study was carried out to test the sensitivity and selectivity of this technique for metastases in lung hila and mediastinum in a group of patients with bronchial cancer. The sensitivity of 57Co-bleo scintigraphy appeared to be higher than that of routine radiological investigations and mediastinoscopy. For this reason it is suggested that 57Co-bleo scintigraphy can be used as a method to select patients for mediastinoscopy.
D000328:Adult; D000368:Aged; D001761:Bleomycin; D001984:Bronchial Neoplasms / Q000175:diagnosis*; D002277:Carcinoma / Q000175:diagnosis*; D003037:Cobalt Radioisotopes; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D008479:Mediastinal Neoplasms / Q000175:diagnosis; D008481:Mediastinoscopy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011446:Prospective Studies; D011877:Radionuclide Imaging / Q000379:methods*
D003037:Cobalt Radioisotopes; D001761:Bleomycin